Physician profile
Narindar Singh
NPI 1992805683
$4,779.95
in general payments reported to CMS, 2019-2025
24 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $919 · 2020: $333 · 2021: $401 · 2022: $1,167 · 2023: $1,201 · 2024: $352 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,888 · Education: $72.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.47 |
| Education | $72.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,090.24 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Glaxosmithkline, LLC. | $811.50 | 2019-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $670.69 | 2022-2024 | Dupixent |
| Astrazeneca Pharmaceuticals Lp | $364.57 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Grifols USA, LLC | $349.18 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $256.82 | 2019-2022 | |
| Genentech USA, INC. | $231.14 | 2019-2022 | |
| Philips North America LLC | $195.78 | 2019-2025 | Vest Therapy Und |
| Baxter Healthcare | $108.64 | 2022-2023 | Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Allergan, INC. | $105.91 | 2019-2020 | |
| Genzyme Corporation | $105.35 | 2022-2023 | |
| Gilead Sciences, INC. | $74.21 | 2022-2023 | |
| Insmed, INC. | $70.79 | 2022-2024 | Arikayce |
| Abbvie INC. | $66.85 | 2022-2025 | Avycaz |
| Janssen Pharmaceuticals, INC | $63.26 | 2019-2024 | Xarelto |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $52.38 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $33.76 | 2025 | Rexulti |
| La Jolla Pharmaceutical Company | $23.72 | 2019 | |
| Edwards Lifesciences Corporation | $21.29 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Sanofi Pasteur INC. | $19.37 | 2019 | |
| Circassia INC. | $17.87 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $16.00 | 2025 | Zoryve |
| Shionogi INC | $15.33 | 2021 | |
| Electromed, INC. | $15.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narindar Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.